Leprosy Disease review

Swapnali S. Dadewad; Sangram U. Deshmukh; Shaymlila B.Bavage; Nandkishor B.Bavage

Leprosy Disease review

Authors: Swapnali S. Dadewad, Sangram U. Deshmukh, Shaymlila B.Bavage, Nandkishor B.Bavage

Unique Paper ID: 152344
Volume: 8
Issue: 3
PageNo: 1-6

Keywords: Epidemiology Disease transmission Classification; Clinical diagnosis Signs and symptoms treatment

Abstract:
Leprosy, also known as Hansenâ€™s disease. Leprosy is chronic infection and caused by Mycobacterium leprae. It is still endemic in many regions of the world and a public health problem in Brazil. a microorganism that has a predilection for the skin and nerves.M. leprae primarily infects Schwann cells in the peripheral nerves leading to nerve damage and the development of disabilities. The mechanism of transmission of leprosy consists of prolonged close contact between susceptible and genetically predisposed individuals and untreated multibacillary patients. Transmission occurs through inhalation of bacilli present in upper airway secretion. The nasal mucosa is the main entry or exit route of M. leprae. In the last few decades, particularly with the advent of multidrug therapy (MDT) and the use of anti-inflammatory therapies, there have been substantial improvements in long-term health outcomes for individuals diagnosed with HD. Although the worldwide prevalence of this disease has significantly decreased.

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 8
Issue: 3
PageNo: 1-6

Leprosy Disease review

Available:https://ijirt.org/Article?manuscript=152344

11 Jan, 2022

EVALUATION OF MARKETED EFFERVESCENT TABLETS

13 Oct, 2021

Bacterial Biofilm Inhibitor

02 Aug, 2021

The risk of death caused by the use of norepinephrine-resistant hypotension in the condition of septic shock in a patient

02 Aug, 2021

COMPUTER AIDED DRUG DESIGN (CADD)

29 Jul, 2021

Impact : Of Second Wave Covid-19 In world

29 Jul, 2021

The use of milrinone for curing a chronic heart failure

20 Jul, 2021

Transdermal Drug Delivery System

13 Jul, 2021

IBUPROFEN: AN OVERVIEW

13 Jul, 2021

CHEMOTHERAPY FOR BREAST CANCER

13 Jul, 2021

USE OF HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY IN THE PHARMACEUTICAL INDUSTRY

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry